We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Effects of a Long-Acting Diquafosol Ophthalmic Solution on the Ocular Surface, Tolerability, and Usability in Dry Eye Disease

    Introduction

    This study aimed to investigate the tolerability of high-viscosity diquafosol tetrasodium (DQS) ophthalmic solution (DIQUAS LX; DQSLX)...

    Minako Kaido, Reiko Arita in Advances in Therapy
    Article 06 May 2024
  2. Tolerability of Antihypertensive Medications: The Influence of Age

    Introduction

    Despite high prevalence of hypertension, few studies have analysed the adverse effects (AEs) of antihypertensive medications, especially...

    Giulia Rivasi, Antonio Coscarelli, ... Andrea Ungar in High Blood Pressure & Cardiovascular Prevention
    Article Open access 24 April 2024
  3. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers

    Background and Objective

    Aberrant accumulation of glycosphingolipids (GSLs) in the lysosome leads to GSL storage diseases. Glucosylceramide synthase...

    Lei Dong, Jianxing **ang, ... Jianhong Zheng in Clinical Drug Investigation
    Article 02 May 2024
  4. Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature

    Increased plasma levels of low-density lipoprotein cholesterol (LDL-C) are causally associated with atherosclerotic cardiovascular disease (ASCVD),...

    Willemijn A. M. Schonck, Erik S. G. Stroes, ... Laurens F. Reeskamp in Drugs
    Article Open access 25 January 2024
  5. Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study

    Introduction

    The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In...

    Taoufik Alsaadi, Reem Suliman, ... Yazan Bader in Neurology and Therapy
    Article Open access 15 February 2024
  6. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance

    Background

    Hereditary fructose intolerance (HFI) is a rare metabolic disease caused by aldolase B deficiency. The aim of our study was to analyse...

    Elsa Izquierdo-García, Andrea Lázaro-Cebas, ... Ismael Escobar-Rodríguez in Orphanet Journal of Rare Diseases
    Article Open access 05 January 2024
  7. Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial

    Background

    We conducted a preliminary phase I, dose-escalating, safety, and tolerability trial in the population of patients with acute intracerebral...

    Nisha C. Durand, H. G. Kim, ... Abba C. Zubair in Neurocritical Care
    Article Open access 19 December 2023
  8. Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers

    Background and Objective

    Deficiencies of enzymes acting downstream of glucosylceramide synthase (GCS) can cause severe substrate accumulation....

    Yingxin Li, Yang Li, ... Aixin Shi in Clinical Drug Investigation
    Article Open access 03 June 2023
  9. Assessing the safety and tolerability of rhinologic surgery under local anesthetic: an 8-year retrospective analysis

    Purpose

    Office-based rhinologic procedures (OBRP) have become widely available in North America due to technological advances and appropriate patient...

    Andrew Kokavec, Sarah Zahabi, ... Leigh J Sowerby in European Archives of Oto-Rhino-Laryngology
    Article 23 April 2024
  10. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review

    Objective

    The objective of this study was to assess the efficacy and tolerability of intranasal midazolam (in-MDZ) administration for antiseizure...

    Tolga D. Dittrich, Dominik Vock, ... Raoul Sutter in Neurocritical Care
    Article Open access 05 April 2024
  11. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis

    Introduction

    Stapokibart, a novel humanized anti-interleukin (IL)-4 receptor alpha monoclonal antibody, inhibits the signaling of IL-4 and IL-13,...

    Libo Zhang, Weilong Zhang, ... Jianzhong Zhang in Advances in Therapy
    Article 04 June 2024
  12. Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction

    Background

    Angiotensin receptor blocker and a neprilysin inhibitor (ARNI) has emerged as an innovative therapy for patients of heart failure with...

    Muhammad Nauman Khan, Najia Aslam Soomro, ... Musa Karim in BMC Cardiovascular Disorders
    Article Open access 13 March 2023
  13. Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer

    Purpose

    Palbociclib has become the standard of care for estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-)...

    Joosje C. Baltussen, Simon P. Mooijaart, ... Johanneke E.A. Portielje in Breast Cancer Research and Treatment
    Article Open access 16 April 2024
  14. An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)

    Background

    Globally, an estimated 260 million people suffer from depression [1], and there is a clear need for the development of new, alternative...

    Carina Joy Donegan, Dimitri Daldegan-Bueno, ... Suresh Muthukumaraswamy in Pilot and Feasibility Studies
    Article Open access 05 October 2023
  15. The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing

    Introduction

    In vitro and pre-marketing clinical data have shown the healing properties of a postbiotic extract from Aquaphilus dolomiae (ADE-G2)....

    Yuling Shi, Edward Lain, ... Aline Stennevin in Dermatology and Therapy
    Article Open access 07 March 2024
  16. Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

    Introduction

    To assess the safety, tolerability and pharmacokinetics of a single dose of SYHA1402 in healthy Chinese subjects.

    Methods ...
    Beibei Liang, ** Wang, ... Yun Cai in Neurology and Therapy
    Article Open access 24 April 2023
  17. Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

    Objectives

    To update and assess the efficacy and tolerability of once weekly subcutaneous semaglutide in patients with type 2 diabetes (T2D).

    ...
    Shanshan Hu, **aorong Su, Guorong Fan in Diabetology & Metabolic Syndrome
    Article Open access 28 October 2023
  18. How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?

    Background

    There is increasing interest in patient-reported measures of cancer treatment tolerability. A global measure of bother, the FACT GP5 item...

    John Devin Peipert, Sara Shaunfield, ... David Cella in Supportive Care in Cancer
    Article Open access 16 December 2022
  19. Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients

    Introduction

    Acquired amyloid neuropathy is an iatrogenic disease that appears years after a domino liver transplant. The objectives of our study are...

    Velina Nedkova-Hristova, Laura Donadeu, ... Carlos Casasnovas in Neurology and Therapy
    Article Open access 10 May 2024
  20. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

    Background

    The intravenous (IV) formulation of Rho-kinase (ROCK) inhibitor fasudil has been approved for the treatment of subarachnoid haemorrhage...

    Andreas W. Wolff, Jörg Peine, ... Paul Lingor in CNS Drugs
    Article Open access 28 February 2024
Did you find what you were looking for? Share feedback.